Back
abrdn Life Sciences Investors Vs. Neurogene Industry Stock Comparison
Sell
36
HQL
abrdn Life Sciences Investors
Last Price:
$13.47
Seasonality Move:
4.03%
Sell
12
NGNE
Neurogene
Last Price:
$22.57
Seasonality Move:
18.83%
Sell
36
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
-
The current abrdn Life Sciences Investors [HQL] share price is $13.50. The Score for HQL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
HQL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $13.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NGNE Stock Price Chart
HQL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 37.01 | Sell |
Chaikin Money Flow: | 74599 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.68 - 14.3) | Sell |
Bollinger Bands (100): | (14.26 - 15.38) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.64 | Sell |
Relative Strength Index (14 RSI): | 40.23 | Sell |
Chaikin Money Flow: | -23511 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.09 - 26.45) | Sell |
Bollinger Bands (100): | (26.19 - 50.01) | Sell |
HQL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.71 | Sell |
20-day SMA: | 13.98 | Sell |
50-day SMA: | 14.47 | Sell |
200-day SMA: | 14.33 | Sell |
8-day EMA: | 13.65 | Sell |
20-day EMA: | 13.94 | Sell |
50-day EMA: | 14.32 | Sell |
200-day EMA: | 14.36 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.05 | Sell |
20-day SMA: | 23.34 | Sell |
50-day SMA: | 37.38 | Sell |
200-day SMA: | 37.89 | Sell |
8-day EMA: | 22.93 | Sell |
20-day EMA: | 25.32 | Sell |
50-day EMA: | 32.11 | Sell |
200-day EMA: | 35.01 | Sell |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
abrdn Life Sciences Investors Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |